Streetbeat News

Revenues

CCL

FDX

KMX

NKE

SCS

The CNN Money Fear and Greed index indicated a decline in market sentiment, moving to the 'Greed' zone with a reading of 71.4. U.S. stocks, including the Dow Jones, S&P 500, and Nasdaq, closed lower, with the Dow ending a nine-day winning streak. FedEx Corporation (FDX) shares dropped over 12% after reporting disappointing Q2 results, while Steelcase Inc. (SCS) shares rose about 11% following positive Q3 earnings. Investors are looking forward to earnings from Carnival Corporation (CCL), CarMax, Inc. (KMX), and NIKE, Inc. (NKE).

Portfolio Pulse from Avi Kapoor

December 21, 2023 | 8:37 am

BA

Boeing Co (NYSE:BA) has received approval from China's Civil Aviation Administration (CAAC) to move forward with resuming 737 MAX deliveries in China, which had been halted since 2019 following two fatal crashes. The approval is a crucial step, but individual aircraft deliveries still require clearance from China's National Development and Reform Commission (NDRC). This progress, along with a recent order from Lufthansa Group for up to 100 737 MAX jets, suggests a growing confidence in the aircraft and is a positive sign for Boeing's recovery, especially considering China's significant share in the global aircraft demand.

Portfolio Pulse from Benzinga Neuro

December 21, 2023 | 4:21 am

MLKN

MillerKnoll, Inc. (NASDAQ:MLKN) reported Q2 earnings of $0.59 per share, beating estimates by 28.26% but saw a sales decline of 11.01% year-over-year, missing expectations. The company improved gross margin and generated $82.4 million in operating cash flow. However, the stock slid after-hours due to a lower-than-expected revenue outlook for Q3 and FY2024, despite higher EPS guidance.

Portfolio Pulse from Ryan Gustafson

December 20, 2023 | 10:14 pm

PK

Park Hotels & Resorts has reaffirmed its 2023 outlook for several key financial metrics as initially provided in its November 1, 2023 earnings press release. The company maintains its expectations for Comparable RevPAR (Revenue per Available Room), Comparable Hotel Adjusted EBITDA Margin, Adjusted EBITDA, and Adjusted Funds From Operations (FFO) Per Share.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 9:47 pm

MIGI

Mawson Infrastructure Group Inc. reported a 47% month-over-month increase in total revenue for November, amounting to approximately $4.81 million. The revenue is equivalent to 132 BTC. The company also completed a co-location customer deployment of about 50 MW and 15,876 miners, and signed an additional co-location customer for approximately 6 MW and 1,764 miners.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 9:43 pm

FLNC

Fluence is actively pursuing owed payments and will dispute allegations made in a counterclaim by Diablo Energy Storage, LLC. The counterclaim was a response to Fluence's initial complaint regarding Diablo's failure to fulfill contract terms, including payment. Fluence asserts that their work on the Diablo Plant was satisfactory and expects payment, deeming the counterclaim meritless. They intend to defend against Diablo's claims while enforcing their own.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 9:29 pm

FORD

Forward Industries, Inc. (NASDAQ:FORD) reported preliminary financial results for FY 2023, with revenues of $36.7M, down 3.9% YoY, and EPS of $0.02, down from $0.04 YoY. The company saw a net loss of $3.7M, increased from $1.4M in 2022. Despite the decline, the design division's IPS subsidiary achieved record revenues. The cash balance increased by 23% to $3.2M. CEO Terry Wise expressed optimism for growth and profitability in the next fiscal year, with plans to grow organically and pursue acquisitions.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 9:12 pm

ATRA

Atara Biotherapeutics has completed an expanded global partnership with Pierre Fabre Laboratories for Tabelecleucel (tab-cel). Atara receives $27 million upfront and initial inventory purchase, with the potential to earn up to $640 million plus royalties on net sales. The deal includes up to $100 million in regulatory milestones through BLA approval, reimbursement of tab-cel global development costs, and future inventory purchases.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 9:05 pm

RGEN

Repligen (NASDAQ:RGEN) has received mixed ratings from 6 analysts in the past three months, with 2 bullish and 4 somewhat bullish ratings. The average 12-month price target is $189.17, with a high of $210.00 and a low of $165.00, reflecting a 7.5% decrease in the average target. Analysts from firms like JP Morgan, UBS, Stifel, RBC Capital, and Keybanc have adjusted their ratings and price targets, responding to market conditions and company performance. Repligen, a life sciences company, has seen a revenue decline of -29.66% as of September 30, 2023, but maintains a strong net margin of 12.87% and an exceptional ROA of 0.72%, with a conservative debt-to-equity ratio of 0.21.

Portfolio Pulse from Benzinga Insights

December 20, 2023 | 9:00 pm

SEIC

SEI Investments (NASDAQ:SEIC) has received mixed analyst ratings over the past quarter, with 8 analysts offering diverse opinions. The average 12-month price target is $62.62, down from $63.38, with a high estimate of $68.00 and a low of $58.00. Analysts from firms like Piper Sandler and Morgan Stanley have adjusted their price targets and ratings, reflecting changes in market dynamics and company performance. SEI Investments provides investment services and has over $1.2 trillion in assets under management. The company's financials show a revenue growth rate of 1.15%, a net margin of 24.26%, an ROE of 5.63%, an ROA of 4.9%, and a low debt-to-equity ratio of 0.01.

Portfolio Pulse from Benzinga Insights

December 20, 2023 | 9:00 pm